Dr. Kate Wolin is a serial entrepreneur and behavioral epidemiologist. She is a co-founder of Coeus Health, which aims to speed the translation of research tested health and wellness programs to the real world. Coeus Health has an SBIR from NIDDK focused on making an evidence-based weight management program that easily integrates into a variety of settings and platforms. She is also a co-host of the To Health With It podcast.
She was previously was CEO and co-founder of ScaleDown, a clinically-proven weight loss program that leverages the science of self-regulation and daily self weighing. ScaleDown was acquired by Anthem, Inc in December 2017. ScaleDown delivered over 12 million weight loss messages from its launch in the fall of 2014 until acquisition.
Dr. Wolin spent much of her career conducting research on the intersection of lifestyle behaviors and chronic-disease outcomes before transitioning to the private sector working to bring evidence-based solutions to market. She has built an international reputation, generating more than $4 million in federal research funding and contributing to over 75 peer-reviewed publications and numerous books.
Dr. Wolin trained as an epidemiologist whose research focuses on the role of lifestyle in reducing risk of chronic diseases, like cancer, and on improving outcomes after a disease diagnosis. Much of her academic research has focused on the role exercise and obesity play in developing cancer and outcomes after a cancer diagnosis. She is a frequent presenter on wellness in community settings and news media (including the Dr. Oz show and Second Opinion). Dr. Wolin obtained her bachelor’s degree in anthropology from Tufts University. She earned her doctorate in epidemiology at the Harvard School of Public Health, with minors in biostatistics and health behavior, where she was an NCI pre-doctoral fellow. Kate is currently an Adjunct Associate Professor in the Department of Preventive Medicine at Northwestern University, where she previously completed a NCI fellowship in cancer epidemiology. Dr. Wolin was previously on the faculty at Washington University School of Medicine in St. Louis / Siteman Cancer Center and Loyola University Chicago’s Stritch School of Medicine. She continues to serve on NIH Study Sections, scientific advisory panels and national research committees.
Kate gets that prevention isn’t always the first priority. Balance and practical advice are central to her messages. You can find Dr. Wolin on Twitter @drkatewolin or on LinkedIn. She can be reached via email: kate @ drkatewolin.com